Mexico participates in Walvax COVID-19 vaccine trials
Media
Dec 7, 2021
adn40
Trials of the Walvax vaccine against COVID-19 are being carried out in Mexico. The product is based on the mRNA, same as the moderna and pfizer vaccines. It is a biologic developed in China and 6,000 volunteers over 18 years of age are being recruited nationally.
Related Links
Apr 14, 2023
Walvax publishes safety and preliminary immunogenicity results from the Phase 1 trial of its bivalent HPV vaccine Walrinvax™ in journal Vaccine
Learn More
Aug 5, 2024
Walrinvax™ Pre-Qualified by WHO
Learn More
May 11, 2022
Walvax Publishes Immunogenicity and Safety Data from Phase 3 Clinical Study of PCV13 (the 2nd available 13-valent pneumococcal polysaccharide conjugate vaccine worldwide) in Frontiers in Microbiology
Learn More